{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:19:24Z","timestamp":1788527964083,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154360","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:38:43Z","timestamp":1785307123000},"page":"154360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["FOXM1 knockdown suppresses hepatoblastoma progression and glycolysis by inhibiting the Wnt\/\u03b2-catenin pathway"],"prefix":"10.1016","volume":"833","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrc.2026.154360_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41572-025-00620-7","article-title":"Hepatoblastoma","volume":"11","author":"Pio","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154360_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26888","article-title":"Do pregnancy characteristics contribute to rising childhood cancer incidence rates in the United States?","volume":"65","author":"Kehm","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"issue":"6","key":"10.1016\/j.bbrc.2026.154360_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5582\/bst.2023.01311","article-title":"An update on diagnosis and treatment of hepatoblastoma","volume":"17","author":"Cao","year":"2024","journal-title":"Biosci Trends"},{"issue":"12","key":"10.1016\/j.bbrc.2026.154360_bib4","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1200\/JCO.2016.70.3249","article-title":"Death within 1 month of diagnosis in childhood cancer: an analysis of risk factors and scope of the problem","volume":"35","author":"Green","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154360_bib5","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3390\/cancers11111777","article-title":"Health status in long-term survivors of Hepatoblastoma","volume":"11","author":"Dembowska-Bagi\u0144ska","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154360_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jhep.2023.05.031","article-title":"Identification and experimental validation of druggable epigenetic targets in hepatoblastoma","volume":"79","author":"Claver\u00eda-Cabello","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2026.154360_bib7","article-title":"FOXM1 and cancer: faulty cellular signaling derails homeostasis","volume":"10","author":"Kalathil","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.154360_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.03.007","article-title":"FOXM1: a small fox that makes more tracks for cancer progression and metastasis","volume":"92","author":"Khan","year":"2023","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154360_bib9","article-title":"Small-molecule inhibitors targeting FOXM1: current challenges and future perspectives in cancer treatments","volume":"1878","author":"Raghuwanshi","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"8052","key":"10.1016\/j.bbrc.2026.154360_bib10","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41586-024-08421-w","article-title":"Targeting FOXM1 condensates reduces breast tumour growth and metastasis","volume":"638","author":"Xie","year":"2025","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.bbrc.2026.154360_bib11","article-title":"FOXM1 inhibition enhances the therapeutic outcome of lung cancer immunotherapy by modulating PD-L1 expression and cell proliferation","volume":"9","author":"Madhi","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"5","key":"10.1016\/j.bbrc.2026.154360_bib12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41419-024-06767-7","article-title":"Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness","volume":"15","author":"Battistini","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154360_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12935-020-01631-y","article-title":"FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A","volume":"20","author":"Yu","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154360_bib14","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ajpath.2020.03.011","article-title":"The Hippo effector transcriptional coactivator with PDZ-binding motif cooperates with oncogenic \u03b2-Catenin to induce hepatoblastoma development in mice and humans","volume":"190","author":"Zhang","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154360_bib15","first-page":"1686","article-title":"Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression","volume":"44","author":"Wu","year":"2020","journal-title":"Oncol. Rep."},{"issue":"14","key":"10.1016\/j.bbrc.2026.154360_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147782","article-title":"FOXM1-CD44 signaling is critical for the acquisition of regorafenib resistance in human liver cancer cells","volume":"23","author":"Wuputra","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154360_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155348","article-title":"FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma","volume":"258","author":"Hino","year":"2024","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154360_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154360_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13045-024-01527-8","article-title":"Metabolic reprogramming in the tumor microenvironment of liver cancer","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.154360_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118118","article-title":"Esculetin inhibits liver cancer by targeting glucose-6-phosphate isomerase mediated glycolysis","volume":"188","author":"Hong","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154360_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s13008-025-00148-y","article-title":"YAP1 activates SLC2A1 transcription and augments the malignant behavior of colorectal cancer cells by activating the Wnt\/\u03b2-catenin signaling pathway","volume":"20","author":"Li","year":"2025","journal-title":"Cell Div."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154360_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/PAP.0000000000000495","article-title":"Hepatoblastoma: comprehensive review with recent updates","volume":"32","author":"Jiao","year":"2025","journal-title":"Adv. Anat. Pathol."},{"issue":"23","key":"10.1016\/j.bbrc.2026.154360_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313044","article-title":"Characterization of an activated metabolic transcriptional program in hepatoblastoma tumor cells using scRNA-seq","volume":"25","author":"Monge","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154360_bib24","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1158\/1078-0432.CCR-13-2407","article-title":"FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression","volume":"20","author":"Cui","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.bbrc.2026.154360_bib25","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1111\/jcmm.17413","article-title":"FOXM1 regulates glycolysis in nasopharyngeal carcinoma cells through PDK1","volume":"26","author":"Yang","year":"2022","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154360_bib26","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3892\/or.2017.5472","article-title":"FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression","volume":"37","author":"Shang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154360_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3727\/105221616X693639","article-title":"Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt\/\u03b2-Catenin perspective","volume":"17","author":"Bell","year":"2017","journal-title":"Gene Expr."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154360_bib28","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20192466","article-title":"Wnt\/\u03b2-catenin signaling as a useful therapeutic target in hepatoblastoma","volume":"39","author":"Sha","year":"2019","journal-title":"Biosci. Rep."},{"issue":"46","key":"10.1016\/j.bbrc.2026.154360_bib29","doi-asserted-by":"crossref","first-page":"17524","DOI":"10.1074\/jbc.RA119.009979","article-title":"\u03b2-Catenin mutations as determinants of hepatoblastoma phenotypes in mice","volume":"294","author":"Zhang","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154360_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4103\/jcrt.jcrt_1575_21","article-title":"Immunohistochemical expression of beta-catenin in hepatoblastoma and its clinical significance","volume":"18","author":"Archana","year":"2022","journal-title":"J. Cancer Res. Therapeut."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154360_bib31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00383-017-4115-2","article-title":"Utility of PAS and \u03b2-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas","volume":"33","author":"Bera","year":"2017","journal-title":"Pediatr. Surg. Int."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154360_bib32","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s11033-024-09694-0","article-title":"Canonical WNT\/\u03b2-catenin signaling upregulates aerobic glycolysis in diverse cancer types","volume":"51","author":"Rathee","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154360_bib33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ajpath.2021.11.007","article-title":"LRP5 promotes gastric cancer via activating canonical Wnt\/\u03b2-Catenin and glycolysis pathways","volume":"192","author":"Nie","year":"2022","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154360_bib34","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/iub.2706","article-title":"2-Deoxy-D-glucose simultaneously targets glycolysis and Wnt\/\u03b2-catenin signaling to inhibit cervical cancer progression","volume":"75","author":"Su","year":"2023","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154360_bib35","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1111\/jcmm.15948","article-title":"FoxM1 promotes Wnt\/\u03b2-catenin pathway activation and renal fibrosis via transcriptionally regulating multi-wnts expressions","volume":"25","author":"Xie","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"17","key":"10.1016\/j.bbrc.2026.154360_bib36","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1158\/1078-0432.CCR-22-0791","article-title":"FOXM1 variant contributes to gefitinib resistance via activating Wnt\/\u03b2-Catenin signal pathway in patients with non-small cell lung cancer","volume":"28","author":"Guan","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154360_bib37","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.21873\/anticanres.11143","article-title":"Therapeutic innovations for targeting hepatoblastoma","volume":"36","author":"Garnier","year":"2016","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154360_bib38","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ymthe.2024.01.036","article-title":"DLK1\/DIO3 locus upregulation by a \u03b2-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis","volume":"32","author":"Sanceau","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2026.154360_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111378","article-title":"Cancer-associated fibroblasts promote the progression and chemoresistance of HCC by inducing IGF-1","volume":"124","author":"Lv","year":"2024","journal-title":"Cell. Signal."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154360_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126434","article-title":"Insulin-like growth factor 1 (IGF-1) signaling in glucose metabolism in colorectal cancer","volume":"22","author":"Kasprzak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.bbrc.2026.154360_bib41","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.18632\/aging.204286","article-title":"Identification of alanine aminotransferase 1 interaction network via iTRAQ-based proteomics in alternating migration, invasion, proliferation and apoptosis of HepG2 cells","volume":"14","author":"Fu","year":"2022","journal-title":"Aging (Albany NY)"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:45:59Z","timestamp":1788525959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26011241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S0006291X26011241"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154360","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXM1 knockdown suppresses hepatoblastoma progression and glycolysis by inhibiting the Wnt\/\u03b2-catenin pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154360"}}